Published on
April 30, 2019
- 07:30 GMT
Cloud Pharmaceuticals to Present AI-Based Drug Design at Conferences in May
COO Don Van Dyke to describe company technology and achievements in designing small molecule and peptide agents. RESEARCH TRIANGLE PARK, NC, UNITED STATES, April 30, 2019 /EINPresswire.com/ -- Don Van Dyke, COO of Cloud Pharmaceuticals Inc., an AI-based …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
